AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Recognizing when to seek financial planning help can significantly impact your financial health. Discover the key signs that indicate it's time to reach out.
22,901 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A two-day injunction hearing opens in federal court in Chicago as Zillow fights to keep access to the Chicagoland MLS...
The Department of Justice is considering dropping charges against accused in the BitClub crypto Ponzi scheme, a move ...
Warren Buffett’s blunt warning that today’s market mood resembles gambling hits a nerve with everyday investors. This...
Bandwidth Inc. released a mixed Q4 2025 report that sheds light on customer growth, margins, and the path to profitab...
OpenAI secures a historic $110 billion funding round from Amazon, Nvidia and SoftBank, driving its valuation to about...
Gabelli’s team signals a long-running capex wave in defense, benefiting both the big primes and smaller suppliers. Al...
In 2026, AI budgets surge while pilots fade. A four‑pillar playbook separates winners from the rest, focusing on data...
A fresh study links Gen Z’s straight‑A trend to lower long‑term earnings, signaling hidden costs behind perfect repor...
United Wholesale Mortgage reports a profitable first quarter as originations slow. CEO Mat Ishbia escalates pressure ...
Federal investigators say encrypted texts reveal Nvidia-linked smuggling patterns tied to China and Russia, highlight...
A February market shock erased roughly $285B in software valuations, forcing a rethink of what truly drives software ...